review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1600-065X.1998.TB01196.X |
P698 | PubMed publication ID | 9700510 |
P50 | author | Hongmin Li | Q54438185 |
P2093 | author name string | R A Mariuzza | |
A Llera | |||
P2860 | cites work | Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site | Q27729723 |
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen | Q27731278 | ||
An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex | Q27733448 | ||
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 | Q27733853 | ||
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen | Q27733857 | ||
The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease | Q27734852 | ||
Dual conformations of a T cell receptor V alpha homodimer: implications for variability in V alpha V beta domain association | Q27739760 | ||
The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain | Q27741302 | ||
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen | Q27748865 | ||
Analysis of binding interactions in an idiotope-antiidiotope protein-protein complex by double mutant cycles | Q30426199 | ||
Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody | Q33887941 | ||
T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens | Q36363962 | ||
Evidence for a functional interaction between the beta chain of major histocompatibility complex class II and the T cell receptor alpha chain during recognition of a bacterial superantigen | Q36363993 | ||
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure | Q36365631 | ||
Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor | Q36366515 | ||
Highly biased CDR3 usage in restricted sets of beta chain variable regions during viral superantigen 9 response | Q36400117 | ||
Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor | Q36400240 | ||
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. | Q36400491 | ||
Kinetic discrimination in T-cell activation | Q37715642 | ||
A mutational analysis of the binding of two different proteins to the same antibody | Q38355029 | ||
T-cell activation by superantigens | Q40626305 | ||
Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology | Q41039639 | ||
The structure of the T cell antigen receptor | Q41039749 | ||
T-cell-receptor affinity and thymocyte positive selection | Q41192128 | ||
Serial triggering of many T-cell receptors by a few peptide-MHC complexes | Q41346263 | ||
T-cell receptor structure and TCR complexes | Q41685092 | ||
Ligand-specific oligomerization of T-cell receptor molecules | Q46536198 | ||
A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes | Q48047077 | ||
Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology | Q59054467 | ||
Crystal structure of staphylococcal enterotoxin B, a superantigen | Q59078216 | ||
P921 | main subject | superantigen | Q772950 |
P304 | page(s) | 177-186 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | Immunological Reviews | Q15724582 |
P1476 | title | Structure-function studies of T-cell receptor-superantigen interactions | |
P478 | volume | 163 |
Q37718638 | Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance |
Q39301452 | FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights |
Q57266797 | Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action |
Q35654266 | Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution |
Q36905471 | High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence. |
Q42677458 | Influence of histidine beta81 of HLA-DR101 on peptide binding and presentation to T-cell receptor |
Q33987727 | Microbial superantigens: from structure to function |
Q30369011 | Overview of protein folds in the immune system. |
Q47314227 | Peptide antagonists of superantigen toxins |
Q41363383 | Secondary mechanisms of diversification in the human antibody repertoire. |
Q42705126 | Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice |
Q33890232 | Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors |
Q40814543 | Superantigen recognition by gammadelta T cells: SEA recognition site for human Vgamma2 T cell receptors |
Q34123105 | Superantigens: microbial agents that corrupt immunity |
Q27639245 | The Three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome |
Q47859097 | Transcriptional response signature of human lymphoid cells to staphylococcal enterotoxin B. |
Q36759362 | What's new in the aetiopathogenesis of vasculitis? |